CombiMatrix Corp. (NASDAQ: CBMX) is a clinical diagnostic laboratory specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. As a full-scale cytogenetic and cytogenomic laboratory, CombiMatrix offers chromosomal microarray analysis, standard and customized FISH, and high resolution karyotyping to help clinicians better care for their patients. CombiMatrix’s operations are made possible due, in large part, to the clinical and molecular diagnostic expertise of its medical team, and the technical expertise of our scientists and laboratory technicians. For more information, visit the company’s website at www.combimatrix.com.